These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26552660)

  • 1. The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch.
    Celik AA; Kraemer T; Huyton T; Blasczyk R; Bade-Döding C
    Immunogenetics; 2016 Jan; 68(1):29-41. PubMed ID: 26552660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
    J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells.
    Crew MD; Cannon MJ; Phanavanh B; Garcia-Borges CN
    Mol Immunol; 2005 Jun; 42(10):1205-14. PubMed ID: 15829309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-E: a novel player for histocompatibility.
    Kraemer T; Blasczyk R; Bade-Doeding C
    J Immunol Res; 2014; 2014():352160. PubMed ID: 25401109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
    Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
    J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways.
    Sasaki H; Xu XC; Mohanakumar T
    J Immunol; 1999 Dec; 163(11):6301-5. PubMed ID: 10570324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.
    Tomasec P; Braud VM; Rickards C; Powell MB; McSharry BP; Gadola S; Cerundolo V; Borysiewicz LK; McMichael AJ; Wilkinson GW
    Science; 2000 Feb; 287(5455):1031. PubMed ID: 10669413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pig-tailed macaques (Macaca nemestrina) possess six MHC-E families that are conserved among macaque species: implication for their binding to natural killer receptor variants.
    Lafont BA; Buckler-White A; Plishka R; Buckler C; Martin MA
    Immunogenetics; 2004 Jun; 56(3):142-54. PubMed ID: 15148641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
    King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
    Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
    Braud VM; Allan DS; Wilson D; McMichael AJ
    Curr Biol; 1998 Jan; 8(1):1-10. PubMed ID: 9427624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire.
    Lauterbach N; Wieten L; Popeijus HE; Voorter CE; Tilanus MG
    Hum Immunol; 2015 Aug; 76(8):578-86. PubMed ID: 26382247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-F Allele-Specific Peptide Restriction Represents an Exceptional Proteomic Footprint.
    Hò GT; Heinen FJ; Blasczyk R; Pich A; Bade-Doeding C
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b.
    Zeng L; Sullivan LC; Vivian JP; Walpole NG; Harpur CM; Rossjohn J; Clements CS; Brooks AG
    J Immunol; 2012 Jan; 188(1):302-10. PubMed ID: 22131332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation.
    Ulbrecht M; Modrow S; Srivastava R; Peterson PA; Weiss EH
    J Immunol; 1998 May; 160(9):4375-85. PubMed ID: 9574542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.
    Sensi M; Pietra G; Molla A; Nicolini G; Vegetti C; Bersani I; Millo E; Weiss E; Moretta L; Mingari MC; Anichini A
    Int Immunol; 2009 Mar; 21(3):257-68. PubMed ID: 19181932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
    Lilienfeld BG; Crew MD; Forte P; Baumann BC; Seebach JD
    Xenotransplantation; 2007 Mar; 14(2):126-34. PubMed ID: 17381687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of the HLA-E and CD94/NKG2 interaction.
    Iwaszko M; Bogunia-Kubik K
    Arch Immunol Ther Exp (Warsz); 2011 Oct; 59(5):353-67. PubMed ID: 21800130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.